This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, S. Articles by Weissman, A. B. Search for Related Content PubMed PubMed Citation Articles by Cohen, S. Articles by Weissman, A. B.

Adverse Effects of Epidural 0.03% Bupivacaine During Analgesia After Cesarean Section

Departments of Anesthesiology, Albert Einstein College of Medicine, Memorial Sloan-Kettering Cancer Center, and Columbia University College of Physicians and Surgeons, New York, New York

To develop a regimen that would provide good analgesia after cesarean section with minimal side effects in the setting of prolonged (>24 h) epidural infusion, buprenorphine or fentanyl was combined with 0.03% bupivacaine in a double-blind study of 23 parturients. Patients were randomly assigned to two groups: group I (n = 12), patient-controlled analgesia by epidural infusion of buprenorphine (3 µ/mL) with 0.03% bupivacaine; group II (n = 11), patient-controlled analgesia by epidural infusion of fentanyl (2 µ/mL) with 0.03% bupivacaine. Plasma for determination of opioid concentrations was obtained at intermittent intervals. Pain relief was similar and satisfactory in both groups. The median overall satisfaction score was higher (10.0 vs 7.5; P < 0.03) for group II. Pruritus was mild in most patients. Nausea and vomiting, which were most disturbing to the patients, were seen only with buprenorphine. No patient had a respiratory rate of <12 breaths/min. Mean plasma opioid concentrations did not exceed 1 ng/mL during the study. However, four patients (33%) in group I and six patients (55%) in group II experienced sensory loss in the lower extremities, which made ambulation difficult. One patient in each group developed extensive pressure blisters on both heels. These complications led us to terminate the study. We conclude that 0.03% bupivacaine used in combination with an opioid in prolonged epidural infusions produces a high incidence of sensory loss in the lower extremities and is unsuitable for situations in which early ambulation is desired.

This article has been cited by other articles:

				R. G. Wheatley, S. A. Schug, and D. Watson Safety and efficacy of postoperative epidural analgesia Br. J. Anaesth., July 1, 2001; 87(1): 47 - 61. [Abstract] [Full Text] [PDF]

				S. Datta and S. Jain Pain Management Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1997; 1(3): 264 - 277. [Abstract] [PDF]